Exhibit 107

Calculation of Filing Fee Tables

Form

S-1

(Form Type)

Rein Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security

Type

Security

Class

Title

Fee

Calculation

Rule

Amount

Registered

(a)

Proposed

Maximum

Offering

Price Per

Unit (b)

Maximum

Aggregate

Offering

Price (b)

Fee Rate

Amount of

Registration

Fee

Fees to Be

Paid

Equity

Common

stock

457(c)

10,000,000

$1.35

$13,500,000

153.10

per

$1,000,000

$2,066.85

Total Offering Amounts

$13,500,000

$2,066.85

Total Fee Offsets

—

Net Fee Due

$2,066.85

(a)	In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover an indeterminate number of additional shares of Common Stock to be offered or issued from stock splits, stock dividends or similar transactions.

(b)	Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act and based upon the average of the high and low sales prices of a share of common stock as reported on the Nasdaq Capital Market on September 2, 2025.

Rein Therapeutics, Inc. S-1